baber/WOPTO huggingface dataset:
Patent NZ-576923-A (NZ)
Title: A stopper cap with a multilayer joint for a bottle neck and a method for making such
Inventor: GRANGER JACQUES
IPC: B65D53/04
Filed: 2007-10-24
Abstract: Disclosed is a stopper cap (1'), having an axial direction (10'), comprising a shell (2'), with a head (20') a skirt (21') and a seal (3) arranged in the shell. The stopper cap is configured to tightly seal the neck of a recipient by axially and laterally compressing the seal between the cap and the neck. The seal is a shaped seal having a center part with an inner surface configured to face the recipient. The shaped seal is a multilayer seal comprising at least a resilient layer and a set of adjacent layers. The adjacent layer comprising at least a layer made of a material to form a barrier against the diffusion of gases, a malleable support layer, and an outer layer made of plastic material.
Patent NZ-577158-A (NZ)
Title: Laminated panel coated with nanoclay particles disposed within a thermoset resin
Inventor: KARAKUS DAVID
IPC: B32B29/00
Filed: 2007-11-05
Abstract: Disclosed is a laminated panel comprising: a core layer having a first side and a second side, which second side is opposite the first side; a decorative layer bonded to the first side of the core layer; and an overcoat layer disposed on a side of the decorative layer opposite the core layer, said overcoat layer containing nanoclay particles disposed in a layer of cured thermoset resin (wherein the nanoclay particles may be selected form synthetic layered silicate particles and naturally occurring aluminosilicate clay mineral particles from the smectite family, such as montmorillonite), which particles have a mean particle size of about 50 mm or less, wherein thermoset resin within the overcoat layer, decorative layer and core layer is cured and bonds the layers together to form the panel.
Patent NZ-579811-A (NZ)
Title: Modified dosage forms of tacrolimus
Inventor: SINGH AMARJIT
IPC: A61K31/4745
Filed: 2008-03-25
Abstract: Disclosed is a modified release dosage form of tacrolimus comprising at least two dosage units wherein at least one dosage unit is an immediate release dosage unit and at least second dosage unit is a delayed release dosage unit wherein said immediate release dosage unit comprises first amount of tacrolimus in an amount of about 10 percent w/w to about 70 percent w/w of the total amount of tacrolimus and one or more excipients selected from group of water soluble carrier, fillers, diluents, binders, disintegrants, stabilizers, surfactants, wetting agents, buffering agents, preservatives, absorption enhancers, wicking agents, glidants, lubricants and solvents; and wherein said delayed release dosage unit comprises second amount of tacrolimus in an amount of about 30 percent w/w to about 90 percent w/w of the total amount of tacrolimus, a delayed release material and one or more excipients selected from group of water soluble carrier, fillers, diluents, binders, disintegrants, stabilizers, surfactants, wetting agents, buffering agents, preservatives, absorption enhancers, wicking agents, glidants, lubricants and solvents and solvents. Tacrolimus is used to prevent transplant rejection in patients.
Patent NZ-586198-A (NZ)
Title: Oros push-stick sustained release dosage forms for controlled delivery of active agents
Inventor: CRUZ EVANGELINE
IPC: A61K31/165
Filed: 2004-09-24
Abstract: A sustained release dosage form for delivering a pharmaceutically active agent to a patient in need thereof, comprising: (1) a semipermeable wall defining a cavity and including an exit orifice formed or formable therein, and (2) an erodible solid contained within the cavity and located adjacent to the exit orifice, said erodible solid comprising a binder, a disintegrant and between 70-90 weight percent of a pharmaceutically active agent, wherein the erodible solid is released from the dosage form through the exit orifice to provide an immediate release and a sustained release of the pharmaceutically active agent. Preferably the pharmaceutically active agent is an aryl propionic acid nonsteroidal anti-inflammatory agent selected from benoxaprofen, decibuprofen, flurbiprofen, fenoprofen, ibuprofen, indoprofen, ketoprofen, naproxen, naproxol, or oxaprozin, or mixtures thereof; the binding agent is a hydroxyalkylcellulose, a hydroxyalkylalkylcellulose, or a polyvinylpyrrolidone; and the disintegrant is croscarmellose, crospovidone, or sodium alginate.
Patent NZ-590788-A (NZ)
Title: Pyrazolopyrimidines and their use for the treatment of cns disorders
Inventor: FUCHS KLAUS
IPC: A61K31/519
Filed: 2009-09-04
Abstract: Disclosed herein are cycloalkyl- or cycloalkenyl-substituted pyrazolopyrimidinones of formula (I), wherein the substituents are as defined within the specification, processes for their preparation, compositions comprising said compounds and uses thereof. Said compounds are useful in the treatment, amelioration or prevention of cognitive impairment being related to perception, concentration, cognition, learning or memory, in particular for the treatment, amelioration or prevention of cognitive impairment being related to age-associated learning and memory impairments, age-associated memory losses, vascular dementia, craniocerebral trauma, stroke, dementia occurring after strokes (post stroke dementia), post-traumatic dementia, general concentration impairments, concentration impairments in children with learning and memory problems, Alzheimer's disease, Lewy body dementia, dementia with degeneration of the frontal lobes, including Pick's syndrome, Parkinson's disease, progressive nuclear palsy, dementia with corticobasal degeneration, amyotropic lateral sclerosis (ALS), Huntington's disease, multiple sclerosis, thalamic degeneration, Creutzfeld-Jacob dementia, HIV dementia, schizophrenia with dementia or Korsakoffs psychosis.
Patent NZ-591369-A (NZ)
Title: Anchor on an insulated cable using wicking material and a liquid settable adhesive
Inventor: PRATLEY KIMLEIGH GEORGE MONTAGUE
IPC: F16J15/02
Filed: 2011-02-24
Abstract: Disclosed is a method of forming an anchor on an insulated cable (110). The method comprises the following steps: · providing a wicking material (112) in contact with the insulation of the cable (110); · introducing a liquid, settable adhesive into the wicking material (112) on the insulated cable (110); and · allowing the liquid, settable adhesive to be wicked into the wicking material (112)and to set as to bond the wicking material (112) to the insulation of the cable (110) and form a projecting anchor or the insulated cable (110).
Patent NZ-597515-A (NZ)
Title: Dispersion of a polyurethane, containing a pesticide
Inventor: SCHNEIDER KARL-HEINRICH
IPC: A01N3/04
Filed: 2010-06-07
Abstract: 597515 Disclosed herein is an aqueous, pesticide-comprising dispersion of a polyurethane which is a reaction product of at least one polyol (A), which are compounds having at least 2 hydroxyl groups, selected from low-molecular weight diols or polyols and polymeric polyols selected from polyester polyols, polycarbonate diols polyacrylate polyols and polyether diols and their mixture, and at least one polyisocyanate (B), which are compounds of the formula X(NCO)2, where X is an aliphatic hydrocarbon radical having 4 to 12 carbon atoms, a cycloaliphatic or aromatic hydrocarbon radical having 6 to 15 carbon atoms, or an araliphatic hydrocarbon radical having 7 to 15 carbon atoms, to plants or plant parts, wherein the polyisocyanate comprises at least 10% by weight of aromatic diisocyanate and at least 10% by weight of aliphatic diisocyanate, in each case based on the polyisocyanate, wherein the dispersion comprises less than 5% by weight of nonionic surface-active substances. Additionally disclosed is a method of treating pests, esca, insect attack, mite attack or fungi in woody plants comprising the step of applying said aqueous, pesticide-comprising dispersion.
Patent NZ-597579-A (NZ)
Title: Novel (6-oxo-1, 6-dihydro-pyrimidin-2-yl)-amide derivatives, preparation thereof, and pharmaceutical use thereof as akt(pkb) phosphorylation inhibitors
Inventor: CARRY JEAN-CHRISTOPHE
IPC: A61K31/513
Filed: 2010-07-01
Abstract: 597579 Disclosed herein are compounds of formula (I), wherein the variables are defined in the specification, process for the preparation thereof, and the use thereof in the treatment in cancer. Specific embodiments of compounds of formula (I) include: 2-[4-(morpholin-4-yl)-6-oxo-1,6-dihydropyrimidin-2-yl]-N-phenylacetamide, N-[3-(dimethylamino)phenyl]-2-[4-(morpholin-4-yl)-6-oxo-1,6-dihydropyrimidin-2-yl]acetamide, 2-[4-(morpholin-4-yl)-6-oxo-1,6-dihydropyrimidin-2-yl]-N-[3-(trifluoromethyl)phenyl]acetamide, Methyl 2-fluoro-5-({ [4-(morpholin-4-yl)-6-oxo-1,6-dihydropyrimidin-2-yl]acetyl} amino) benzoate, and 2-[2-(4-fluoro-2,3-dihydro-1H-indol-1-yl)-2-oxoethyl]-6-(morpholin-4-yl)pyrimidin-4(3H)-one.
Patent NZ-601981-A (NZ)
Title: Targeted cryptosporidium biocides
Inventor: IMBODEN MICHAEL
IPC: A01N63/02
Filed: 2010-01-13
Abstract: Disclosed is a composition comprising a recombinant fusion protein, wherein said fusion protein comprises an immunoglobulin that binds to a Cryptosporidium spp., wherein said immunoglobulin comprises a pair of polypeptides comprising a heavy chain and a light chain and wherein the variable regions of said pair of polypeptides have amino acid sequences of METDTLLLWVLLLWVPGSTGDQVQLQQSGAELAKPGASVKMSCKASGYTFTSYWMHWVKQRPGQGLEWIGYINPSTGYPEYNQKFKDKATLTADKSSNTAYMQLSSLTSEDSAVYYCVRRNYYEDFFDYWGQGTTLTVSSA and METDTLLLWVLLLWVPGSTGDVVMTQIPLSLPVSLGDQASISCRSSQSLVHSNGNTYLHWYLQKPGQSPKVLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDLGVYFCSQSTHVPLTFGAGTKLELKRA or sequences that are at least 95% identical to the recited sequences; and wherein said immunoglobulin is joined to at least a portion of a protein biocide molecule.
Patent NZ-602059-A (NZ)
Title: Milk plastic container with formations to allow tight nesting of diamond shaped bottles
Inventor: GLOVER ANDREW
IPC: B65D1/02
Filed: 2012-08-27
Abstract: A plastics container for storing a liquid, comprising a body with an integral 5 handle, the handle defining a handle eye with a central axis extending in a first direction through the body, and the body having a footprint with a longitudinal axis extending in a second direction which is perpendicular to the first direction, wherein the footprint has a width which varies along its longitudinal axis and is greatest at a middle region of the footprint and smallest at either longitudinal end 10 of the footprint, the footprint having two generally opposing longitudinal end surfaces separated by four angled side surfaces, and the middle region of the footprint defining opposing transverse ends of the footprint on either side of the longitudinal axis, wherein the internal angles of the transverse ends of the footprint are greater than the internal angles at the longitudinal ends of the 15 footprint. 20 2. A container according to claim 1 wherein the footprint is at least partially diamond-shaped, having two generally opposing longitudinal end surfaces separated by four angled side surfaces. 3. A container according to claim 1 or claim 2 wherein the body defines a chamber for storing liquid with the chamber extending into and/or through the integral handle. 25 4. A container according to any of claims I to 3 wherein the footprint further comprises a peripheral step for aligning the body in a predetermined orientation relative to an external datum. 5. A container according to any of claims 1 to 4 including a neck mounted on and 30 extending from the body, the neck having an open passageway therethrough for passage of liquid to/from the chamber; wherein the neck and body intersect in a closed loop which has a non-planar profile.
Patent NZ-603598-A (NZ)
Title: Capsule, system and method for preparing a beverage by centrifugation
Inventor: JARISCH CHRISTIAN
IPC: B65D85/804
Filed: 2011-05-12
Abstract: A capsule for the preparation of a beverage comprising a container and a beverage ingredient contained therein, where the container comprises a code 72 adapted for being identified or read by external reading means 62, wherein the code 72 is arranged on the container to be read while the capsule is rotated around an axis of rotation traversing the capsule. The code 72 comprises successive segments that are individually rectilinear. The capsule has a circumference and the successive segments of the code 72 extend substantially along at least an eighth of the circumference. The container comprises a cup-shaped body 3 having a flange-like rim and a lid connected to the body. The code 72 is present on a bottom of the rim, and the bottom of the rim is opposed to the lid.
Patent NZ-604507-A (NZ)
Title: Glass container with internally threaded neck
Inventor: BRIGNOLO GINO GIOVANNI
IPC: B67B1/06
Filed: 2011-05-30
Abstract: 604507 The present disclosure relates to a glass container with a cylindrical neck (1) suitable for plugging the container by means of a stopper inserted in said neck, said neck (1) comprises an internal thread (6) allowing for reversible plugging and unplugging of the container by screwing and unscrewing said stopper, wherein the internal thread (6) of the neck consists of at least two independent thread turns (7) allowing unplugging and plugging of the container by screwing and respectively unscrewing the stopper by rotating it over an angle of less than 180°.
Patent NZ-605491-A (NZ)
Title: Fused heterocyclic derivatives as s1p modulators
Inventor: IWEMA BAKKER WOUTER I
IPC: A61K31/429
Filed: 2011-07-08
Abstract: The disclosure relates to a fused heterocyclic derivative of the formula (I), wherein the variables R1-R4, z, A, Q, X and Y are as defined in the specification. 4-{ 2-[4-(2-Fluoro-benzyloxy)-phenyl]-6,7-dihydro-4H-furo[3,2-c]pyridine-5-yl} -butyric acid is a typical example of said fused heterocyclic derivative. These compounds of formula (I) are modulators of the S1P receptor (Sphingosine-1-phosphate receptor). More specifically, they are agonists of S1P5. The compounds have therapeutic use in treatment of neurodegenerative disorder, in particular selected from a cognitive disorder, Alzheimer’s disease, (vascular) dementia, Nieman’s Pick disease, and cognitive deficits in schizophrenia, obsessive-compulsive behaviour, major depression, autism, multiple sclerosis and pain, and specifically a cognitive disorder, such as age-related cognitive decline.
Patent NZ-606827-A (NZ)
Title: Agonists of gpr40
Inventor: RANGANATH RAO JAGANNATH MADANAHALLI
IPC: C07F9/40
Filed: 2011-07-20
Abstract: Disclosed herein are compounds of general formula I, wherein the substituents are as defined in the specification, processes for their preparation, compositions comprising said compounds and uses thereof. Said compounds are useful as agonists of GPR40 and as such are useful in the treatment of cognitive disorders, osteoporosis, inflammatory disorders, diabetes, obesity, hyperglycemia. glucose intolerance. insulin resistance, hyperinsulemia, hypercholesteremia, hypertension, hyper!ipoproteinemia, hyperlipidemia. hypertriglyceridemia, dyslipedemia, metabolic syndrome, syndrome X, cardiovascular disease. atherosclerosis, kidney disease, ketoacidosis, thrombotic disorders, nephropathy, diabetic neuropathy, diabetic retinopathy, sexual dysfunction, dermatopathy, dyspepsia, hypoglycemia. cancer and edema. Examples of particularly preferred compounds include: 3-{ 2-Fluoro-4-[(4-{ [(2Z)-2-(methoxyimino)-2-phenylethyl]oxy} benzyl)oxy]phenyl} propanoic acid; 3-{ 4-[(4-{ [(2Z)-2-(4-Cyanophenyl)-2-(methoxyimino)ethyl]oxy} benzyl)oxy]-2-fluorophenyl} propanoic acid; 2-{ 4-[{ 4-{ [(2Z)-2-(4-Cyanophenyl)-2-(methoxyimino)ethyl]oxy} benzyl)oxy]phenyl} cyclopropanecarboxylic acid; Sodium 3-cyano-3-{ 4-[(4-{ [(2Z)-2-(4-fluorophenyl)-2-(methoxyimino)ethyl]oxy} benzyl)oxy] phenyl} propanoate.
Patent NZ-607406-A (NZ)
Title: Wall structure working as a noise barrier for railways and use of the wall structure as a noise or passage barrier
Inventor: AIRAKSINEN JARMO
IPC: E06B11/04
Filed: 2011-07-26
Abstract: A wall structure (1) working as a noise barrier for railways is disclosed. The wall has a plurality of wall elements (2) placed consecutively end-to-end with each other. The wall elements are hinged by means of hinge pieces at their bottom edges so that they can be rotated downwards from their vertical position. The wall elements (2) are mounted inside the width reach (W) of the wagons or cargo space of a train. When a wagon or a load is lower than normal and/or is over-wide the wall structure can be lowered out of the way.
Patent NZ-607706-A (NZ)
Title: System and method for generating electrical power from a flowing current of fluid
Inventor: SINCLAIRE ROSS
IPC: F03B17/06
Filed: 2011-08-11
Abstract: A helical turbine (20A, 20B) is operatively connected to at least one generator system for generating electrical power. System performance is optimized by controlling the operative angle between the longitudinal axis (40A, 40B) of the turbine and the direction of the current flow and by controlling a pitch ratio of the turbine. A pair of turbines (20A, 20B), arranged in V-shape, each at the operative angle from a neutral centreline, provides symmetry and counteracts reactive torque. For wind operations, the V- shape is freely rotatable into the wind. For bi-directional tidal operations, the V- shape is part of a buoyant structure, positioned in the current and anchored to the floor. The structure is fit with control surfaces to ensure the system orientation. In unidirectional currents, one or more turbines can be angled downwardly into the current at the operative angle, elevators ensuring the angle is maintained.
Patent NZ-609160-A (NZ)
Title: An effluent treatment unit
Inventor: LANGFORD JOSEPH DANIEL
IPC: E03F11/00
Filed: 2011-10-21
Abstract: An effluent treatment unit 10 is disposed within a primary treatment tank 400. When effluent enters the primary treatment tank it separates into three layers of sludge 414, liquid effluent 416, and scum 418. The liquid effluent layer 416 is relatively clear with some dissolved or suspended organic contaminants. Further treatment of liquid effluent 416 is required before discharge, and outlet filters tend to become blocked or clogged. The effluent treatment unit 10 comprises a reactor tank; a down-flow media region 202; an up-flow media region 204, an inlet opening 120; an outlet opening 412; a separator (not indexed) and bacterial support media 300. The down-flow 202 and up-flow 204 media regions are located in the reactor tank and are separated from one another by the separator. The inlet opening 120 is formed within the reactor tank through which effluent can flow into the down-flow media region 202. The outlet opening is formed within the reactor tank through which effluent can flow out of the up-flow media region 204. The outlet opening is located further up than the inlet opening 120. The bacterial support media 300 is located in the down-flow media region 202 for providing bacterial residence in that region 202. The bacterial support media 300 is located below the inlet opening 120.
Patent NZ-609660-A (NZ)
Title: Methods of isolating non-senescent cardiac stem cells and uses thereof
Inventor: ANVERSA PIERO
IPC: A61K35/12
Filed: 2011-11-02
Abstract: Disclosed is a pharmaceutical composition comprising a population of isolated human adult c-kit positive cardiac stem cells and a pharmaceutically acceptable carrier, wherein at least 50% of said isolated cardiac stem cells have immortal DNA. Also disclosed is a substantially pure population of adult cardiac stem cells which are c-kit positive, IGF-1 receptor positive, p16INK4a negative, and have immortal DNA. Further disclosed is a method for isolating adult cardiac stem cells having immortal DNA comprising: (a) exposing adult cardiac stem cells to a DNA label, wherein said cardiac stem cells are c-kit positive and isolated from myocardial tissue; (b) culturing said labelled cardiac stem cells for at least one population doubling; and (c) selecting the cardiac stem cells that are negative for the DNA label, wherein said selected stem cells are cardiac stem cells having immortal DNA.
Patent NZ-617484-A (NZ)
Title: Animal identification tag
Inventor: TOWNSEND GRANT
IPC: A01K11/00
Filed: 2012-05-17
Abstract: An animal identification ear tag (1) is disclosed. The ear tag includes a male pin (2) having a first end and a second end (17) configured to penetrate an animal’s ear having a locking shoulder (26) adjacent the second end. The male pin (2) contains an electronic RFID tag component suspended in a cushioning material such as a gel, grease or foam. The first end of the pin is either formed integrally with or configured to be coupled to a single piece moulded panel (3). The panel (3) includes a female portion (5) with an opening (6) to receive the second end (17) of the male pin including the locking shoulder (26) and a panel body (4) extending from the first portion to the female portion (5). The opening (6) includes a plurality of locking projections extending inwardly.
Patent NZ-618741-A (NZ)
Title: Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
Inventor: SCHUELE MARTIN
IPC: C07D413/14
Filed: 2010-04-30
Abstract: Disclosed is a monohydrate of an oxodihydropyridine ethyl phenyl pyridine substituted [1,3]oxazinan-2-one compound of formula (Ip1). An example of compounds of formula (Ip1) is (S)-6-(2-hydroxy-2-methylpropyl)-3-((S)-1-(4-(1-(2-hydroxyethyl)-6-oxo-1,6-dihydropyridin-3-yl)phenyl)ethyl)-6-phenyl-1,3-oxazinan-2-one. Also disclosed are pharmaceutical compositions of the compounds and methods for their use in the reduction or control of the production of Cortisol in a cell or the inhibition of the conversion of cortisone to Cortisol in a cell and for the treatment of Type II diabetes mellitus, obesity, glucose intolerance, hyperglycemia, hyperlipidemia, insulin resistance, and dyslipidemia.
Patent NZ-619609-A (NZ)
Title: Method for manufacturing an aerated confectionery shell
Inventor: HAUGER RUDOLF
IPC: A23G3/52
Filed: 2012-06-29
Abstract: Disclosed is a method for manufacturing an aerated confectionery shell comprising the steps of: (i) aerating a liquid chocolate; (ii) depositing the aerated liquid chocolate into a mould cavity; and (iii) pressing the aerated liquid chocolate in the mould cavity using a stamp having a surface temperature below the solidification temperature of the liquid chocolate so as to shape and at least partially solidify the liquid, thereby forming an aerated shell layer; wherein the aerated shell layer has a total gas content of at least 5%, the gas content being calculated using the following formula (1): Gas content of aerated shell layer = (M2-M1)/M2 Gas content of aerated shell layer = M2 - M1/M2 where M1 is the mass of the aerated shell layer having volume V1, and M2 is the mass of a non-aerated shell layer having volume V1 and being formed from the same edible liquid as the aerated shell layer and in the same manner as the aerated shell layer.
Patent NZ-621271-A (NZ)
Title: Gasification of carbonaceous material
Inventor: BAUMANN PAUL SMIT
IPC: F23H9/02
Filed: 2012-07-24
Abstract: A grate assembly (10) for a gasifier for gasifying carbonaceous material producing ash includes an upper rotatable grate component (11) and a lower rotatable support structure (12) fastened to the upper rotatable grate component (11) by a plurality of removable fasteners (15) acting to prevent vertical displacement of the upper rotatable grate component (11) and the lower rotatable support structure (12). The lower rotatable support structure (12) is configured to be drivingly rotated about a common vertical axis of rotation (21) shared with the upper rotatable grate component (11). The assembly (1) further includes at least two key torque transmitters (16) spaced angularly relative to the common axis of rotation (21) and engaging the upper rotatable grate component (11) and the lower rotatable support structure (12) to transfer torque from the lower rotatable support structure (12) to the upper rotatable grate component (11) when the lower rotatable support structure (12) is driven.